Amicus’ oral Fabry disease drug approved in USDecision follows approval in Europe Share XAmicus’ oral Fabry disease drug approved in UShttps://pharmaphorum.com/news/amicus-oral-fabry-disease-drug-approved/
Amicus set for share of Fabry market after NICE approvalEngland and Wales’ cost effectiveness watchdog NICE has given a final recommendation to a new treatment for the Share XAmicus set for share of Fabry market after NICE approvalhttps://pharmaphorum.com/news/amicus-set-share-fabry-market-nice-approval/
